retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity Dosage & Titration: Complete Escalation Protocol (5-30 mg) Obesity drug research, triple G
Description
Compounded semaglutide from online pharmacies without a proper medical consultation carries serious safety risks including unknown purity, incorrect dosing, and no monitoring for side effects or contraindications
J Card Fail 21:28
Thus, the QU's accountability cannot be transferred to a bot
A national shortage of weight loss medications in 2022 opened the door for compounding pharmacies to manufacture these drugs
One challenge to the whole GLP-1 landscape is access to them in the first place, between shortages, high costs, and lack of insurance coverage
